Astellas Announces Acquisition of Quethera
Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy...
read more
Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy...
read moreCAMBRIDGE, UK, 11 June 2018—Silicon Microgravity (SMG), a spin-out from both BP and the...
read moreUpdate your browser to view this website correctly.Update my browser now